E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study

Bharathi C, Sathis CS, Niruba R, Hemamalini T.

Abstract
Background: There has been an increasing prevalence of diabetes worldwide. Diabetic peripheral neuropathy is the most common complication of type I and II diabetes. Peripheral neuropathy is a damage occurring in the nerves due to prolonged higher levels of blood sugar and diabetes. There are various screening tests such as vibration perception threshold (VPT), neuropathy symptom profile, michigan neuropathy screening instrument, neuropathy disability score, and Michigan diabetic neuropathy score. VPT accounts for an easy and accurate identification of diabetic patients, who are at risk, including patients, with early neuropathic deficits. Toronto clinical neuropathy score (TCNS) has been validated as a score for monitoring and diagnosing diabetic peripheral neuropathy.

Aims and Objectives: This study was done to estimate the sensitivity, evaluate specificity, and determine the positive predictive value and negative predictive value of TCNS scoring in diabetic peripheral neuropathy patients considering VPT as the gold standard.

Materials and Methods: In this study, VPT and TCNS were determined in 100 type 2 diabetic subjects with signs and symptoms of peripheral neuropathy.

Results: In this study, it was estimated that TCNS is a reliable measure of distal poly neuropathy with a sensitivity of 95.83%, 100% specificity, positive predictive value of 100%, and negative predictive value of 50%.

Conclusion: From our study, it was found that TCNS is a sensitive indicator of definite clinical neuropathy.

Key words: Diabetes; Vibration Perception Threshold; Toronto Clinical Neuropathy Score


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Bharathi C
Articles by Sathis CS
Articles by Niruba R
Articles by Hemamalini T
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

C B, CS S, R N, T H. Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study. Natl J Physiol Pharm Pharmacol. 2024; 14(2): 270-274. doi:10.5455/njppp.2023.13.06316202313072023


Web Style

C B, CS S, R N, T H. Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study. https://www.njppp.com/?mno=156830 [Access: January 31, 2024]. doi:10.5455/njppp.2023.13.06316202313072023


AMA (American Medical Association) Style

C B, CS S, R N, T H. Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study. Natl J Physiol Pharm Pharmacol. 2024; 14(2): 270-274. doi:10.5455/njppp.2023.13.06316202313072023



Vancouver/ICMJE Style

C B, CS S, R N, T H. Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study. Natl J Physiol Pharm Pharmacol. (2024), [cited January 31, 2024]; 14(2): 270-274. doi:10.5455/njppp.2023.13.06316202313072023



Harvard Style

C, B., CS, . S., R, . N. & T, . H. (2024) Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study. Natl J Physiol Pharm Pharmacol, 14 (2), 270-274. doi:10.5455/njppp.2023.13.06316202313072023



Turabian Style

C, Bharathi, Sathis CS, Niruba R, and Hemamalini T. 2024. Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study. National Journal of Physiology, Pharmacy and Pharmacology, 14 (2), 270-274. doi:10.5455/njppp.2023.13.06316202313072023



Chicago Style

C, Bharathi, Sathis CS, Niruba R, and Hemamalini T. "Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 270-274. doi:10.5455/njppp.2023.13.06316202313072023



MLA (The Modern Language Association) Style

C, Bharathi, Sathis CS, Niruba R, and Hemamalini T. "Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study." National Journal of Physiology, Pharmacy and Pharmacology 14.2 (2024), 270-274. Print. doi:10.5455/njppp.2023.13.06316202313072023



APA (American Psychological Association) Style

C, B., CS, . S., R, . N. & T, . H. (2024) Assessing the effectiveness of Toronto clinical neuropathy score in diagnosing diabetic peripheral neuropathy – A descriptive comparative study. National Journal of Physiology, Pharmacy and Pharmacology, 14 (2), 270-274. doi:10.5455/njppp.2023.13.06316202313072023